• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.

作者信息

Liguori Claudio, Stefani Alessandro, Ruffini Roberta, Mercuri Nicola Biagio, Pierantozzi Mariangela

机构信息

Sleep Disorders Centre, Department of Systems Medicine, University of Rome "Tor Vergata", Italy; Parkinson's Centre, University Hospital of Rome "Tor Vergata", Italy.

UOSD Parkinson, University Hospital of Rome "Tor Vergata", Italy.

出版信息

Parkinsonism Relat Disord. 2018 Dec;57:80-81. doi: 10.1016/j.parkreldis.2018.06.033. Epub 2018 Jun 30.

DOI:10.1016/j.parkreldis.2018.06.033
PMID:30006034
Abstract
摘要

相似文献

1
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.沙芬酰胺对运动波动型帕金森病患者睡眠障碍和日间嗜睡的影响：一项经过验证的问卷调查对照研究。
Parkinsonism Relat Disord. 2018 Dec;57:80-81. doi: 10.1016/j.parkreldis.2018.06.033. Epub 2018 Jun 30.
2
Safinamide effect on sleep architecture of motor fluctuating Parkinson's disease patients: A polysomnographic rasagiline-controlled study.沙芬酰胺对运动波动型帕金森病患者睡眠结构的影响：一项与雷沙吉兰对照的多导睡眠图研究。
Parkinsonism Relat Disord. 2024 Oct;127:107103. doi: 10.1016/j.parkreldis.2024.107103. Epub 2024 Aug 13.
3
Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study.在帕金森病波动患者中从雷沙吉兰转换为沙芬酰胺：一项回顾性、初步研究。
Neurol Res. 2021 Nov;43(11):950-954. doi: 10.1080/01616412.2021.1942408. Epub 2021 Jun 18.
4
Rasagiline and safinamide as a dopamine-sparing therapy for Parkinson's disease.雷沙吉兰和沙芬酰胺作为一种多巴胺保留疗法治疗帕金森病。
Acta Neurol Scand. 2019 Jul;140(1):23-31. doi: 10.1111/ane.13096. Epub 2019 Apr 22.
5
Safinamide (Xadago) for Parkinson's disease.沙芬酰胺（Xadago）用于治疗帕金森病。
Med Lett Drugs Ther. 2017 Sep 11;59(1529):151-153.
6
Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.在受特发性帕金森病影响的患者队列中，沙芬酰胺对非运动症状的疗效。
Neurol Sci. 2019 Feb;40(2):275-279. doi: 10.1007/s10072-018-3628-3. Epub 2018 Oct 31.
7
Safinamide in the treatment of Parkinson's disease.沙芬酰胺治疗帕金森病。
Expert Opin Pharmacother. 2010 Sep;11(13):2261-8. doi: 10.1517/14656566.2010.511612.
8
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.司来吉兰作为左旋多巴附加治疗中晚期帕金森病的两年随机对照研究。
Mov Disord. 2014 Sep;29(10):1273-80. doi: 10.1002/mds.25961. Epub 2014 Jul 10.
9
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.沙芬酰胺治疗帕金森病的临床药理学综述
Neurodegener Dis Manag. 2015 Dec;5(6):481-96. doi: 10.2217/nmt.15.46. Epub 2015 Nov 20.
10
Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.沙芬酰胺可改善帕金森病患者的睡眠和日间嗜睡：SAFINONMOTOR 研究结果。
Neurol Sci. 2022 Apr;43(4):2537-2544. doi: 10.1007/s10072-021-05607-2. Epub 2021 Sep 23.

引用本文的文献

1
Use of safinamide for treatment of Parkinson disease: real-world data from Spain.沙芬酰胺用于治疗帕金森病：来自西班牙的真实世界数据。
Drugs Context. 2025 Jul 25;14. doi: 10.7573/dic.2025-5-5. eCollection 2025.
2
Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson's Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose.根据性别、年龄、病程和左旋多巴等效日剂量评估沙芬酰胺对帕金森病患者非运动症状和生活质量的影响
Brain Sci. 2025 Jun 20;15(7):666. doi: 10.3390/brainsci15070666.
3
Optimized use of safinamide as an add-on therapy in Asian patients with Parkinson's disease: a narrative review and expert opinion.
沙芬酰胺在亚洲帕金森病患者中作为附加疗法的优化使用：叙述性综述与专家意见
Ther Adv Neurol Disord. 2025 Apr 17;18:17562864251329099. doi: 10.1177/17562864251329099. eCollection 2025.
4
The Role of MAO-B Inhibitors in Fatigue in Parkinson's Disease: A Narrative Review.单胺氧化酶B抑制剂在帕金森病疲劳中的作用：一项叙述性综述
J Clin Med. 2025 Apr 10;14(8):2598. doi: 10.3390/jcm14082598.
5
The Influence of Gender and Length of Therapy Use on Sleep Quality in Patients with Parkinson's Disease.性别及治疗用药时长对帕金森病患者睡眠质量的影响
Mater Sociomed. 2025;37(1):58-63. doi: 10.5455/msm.2025.37.58-63.
6
Long-Term Real-World Experience with Safinamide in Patients with Parkinson's Disease.沙芬酰胺治疗帕金森病患者的长期真实世界经验
Brain Sci. 2024 Dec 9;14(12):1238. doi: 10.3390/brainsci14121238.
7
Effects of Safinamide on Motor and Non-Motor Symptoms in Patients with Parkinson's Disease and Motor Fluctuations.沙芬酰胺对帕金森病伴运动波动患者运动和非运动症状的影响。
Eur Neurol. 2024;87(5-6):291-305. doi: 10.1159/000541362. Epub 2024 Sep 27.
8
Effectiveness and safety of safinamide in the Toledo Movement Disorders Unit.在托莱多运动障碍科，沙芬酰胺的疗效和安全性。
Rev Neurol. 2023 Oct 31;77(S03):S1-S7. doi: 10.33588/rn.77S03.2023212.
9
Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.沙芬酰胺对帕金森病患者报告结局的影响。
Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023.
10
Real-world use of Safinamide in motor fluctuating Parkinson's disease patients in Italy.意大利真实世界中使用沙芬酰胺治疗运动波动型帕金森病患者。
Neurol Sci. 2024 Feb;45(2):573-583. doi: 10.1007/s10072-023-07001-6. Epub 2023 Sep 9.